Smith & Nephew rebuffs bid from J & J

Share this article:

Wound care firm Smith & Nephew rejected a $10.9 billion acquisition offer from Johnson & Johnson.

Smith & Nephew CEO David Illingworth declined to comment on the bid, sending his firm's stock prices soaring by more than 10%. “Speculation has been going on for 10 years,” he said at a J.P. Morgan Healthcare Conference in San Francisco.

J&J spokesman Jeff Leebaw also declined comment.

Sky News reported that Johnson & Johnson approached its rival in December with the  11-figure proposal. But the outlet did not cite sources, or indicate where it had received its information.

Johnson & Johnson was considering whether or not to come back with a raised offer, according to several other published reports.

The allegation that Smith & Nephew received and rejected a bid without informing shareholders reopened debate on when companies should be required to make bids known to the market.

It is generally accepted that companies should not have to reveal all bids received. Some argue that there must be something wrong with the system if boards can withhold information about serious bids.
Share this article:

More in News

Hospitals in the Midwest refer patients to the broadest networks of skilled nursing facilities, study finds

Hospitals in the Midwest refer patients to the ...

Midwestern hospitals spread referrals to the greatest variety of skilled nursing facilities and tap their favorite SNFs least often, according to a recently published analysis of nationwide referral patterns.

Bill would affect pay, scheduling for some nursing home housekeeping staff

Nursing homes could face more stringent scheduling requirements for housekeeping workers and might be on the hook to compensate them for last-minute shift changes under a bill proposed in both houses of Congress.

Joint Commission adds memory care accreditation

New memory care accreditation for nursing homes encourages staff to use a flexible, problem-solving approach to care for those with dementia, according to Joint Commission guidelines.